Hochschulschrift
Molecular characterization of solid tumors to inform precision oncology decisions by next generation sequencing panels
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
XVIII, 191 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Johannes Gutenberg-Universität Mainz, Dissertation, 2022
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:57 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2022
Other Objects (12)
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets
Tackling precision oncology using heterogeneous omics data sets
Translating Next-Generation-Sequencing into Precision Medicine
Multiomics analysis of pediatric solid tumors within the INFORM precision oncology study: from functional drug profiling to biomarker identification [Abstract]
The role of key pharmacodynamic and pharmacokinetic parameters in drug response prediction of pediatric tumors in the precision oncology study INFORM
Automated Identification of Targeted Therapy Strategies in Precision Oncology
Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology
Precision oncology based on omics data: the NCT Heidelberg experience
Applying machine learning to derive actionable insights in precision oncology
Precision oncology for upper GI cancers – where are we heading?
Applying machine learning to dervive actionable insights in precision oncology
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets
Tackling precision oncology using heterogeneous omics data sets
Translating Next-Generation-Sequencing into Precision Medicine
Multiomics analysis of pediatric solid tumors within the INFORM precision oncology study: from functional drug profiling to biomarker identification [Abstract]
The role of key pharmacodynamic and pharmacokinetic parameters in drug response prediction of pediatric tumors in the precision oncology study INFORM
Automated Identification of Targeted Therapy Strategies in Precision Oncology
Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology
Precision oncology based on omics data: the NCT Heidelberg experience
Applying machine learning to derive actionable insights in precision oncology
Precision oncology for upper GI cancers – where are we heading?
Applying machine learning to dervive actionable insights in precision oncology
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets
Tackling precision oncology using heterogeneous omics data sets
Translating Next-Generation-Sequencing into Precision Medicine
Multiomics analysis of pediatric solid tumors within the INFORM precision oncology study: from functional drug profiling to biomarker identification [Abstract]
The role of key pharmacodynamic and pharmacokinetic parameters in drug response prediction of pediatric tumors in the precision oncology study INFORM
Automated Identification of Targeted Therapy Strategies in Precision Oncology
Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology
Precision oncology based on omics data: the NCT Heidelberg experience
Applying machine learning to derive actionable insights in precision oncology
Precision oncology for upper GI cancers – where are we heading?